Blog

Merck Canada Inc. announced today that Keytruda (pembrolizumab) was authorized for sale with conditions by Health Canada on May 19, 2015. ...

Aprecia Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s New Drug ...

Astellas Pharma Canada, Inc., the Canadian subsidiary of Tokyo-based Astellas Pharma, Inc., announced today that Health Canada has approved a ...

Women with HER2-positive metastatic breast cancer in British Columbiawill now be able to access a new treatment option through the BC ...

[:content [\1 \0 \space \J \a \n \u \a \r \y \space \2 \0 \1 \4 \space \- \space \T \h \e \space \p \C \O \D \R \space \E \x \p \e \r \t \space \R \e \v \i \e \w \space \C \o \m \m \i \t \t \e \e \space \( \p \E \R \C \) \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \t \h \e \space \f \i \n \d \i \n \g \space \o \f \space \t \r \a \s \t \u \z \u \m \a \b \space \e \m \t \a \n \s \i \n \e \space \( \K \a \d \c \y \l \a \) \space \f \o \r \space \p \a \t \i \e \n \t \s " ..."]]

[:content [\5 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \space \T \h \e \space \p \C \O \D \R \space \E \x \p \e \r \t \space \R \e \v \i \e \w \space \C \o \m \m \i \t \t \e \e \space \( \p \E \R \C \) \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \t \h \e \space \f \u \n \d \i \n \g \space \o \f \space \d \a \b \r \a \f \e \n \i \b \space \m \e \s \y \l \a \t \e \space \( \T \a \f \i \n \l \a \r \) \space \i \n \space \C \a \n \a \d \a " ..."]]

Novartis Pharmaceuticals Canada Inc. is pleased to announce that Health Canada has issued a marketing authorization with conditions for Zykadia (ceritinib), a ...

[:content [\N \I \C \E \  \h \a \s \space \i \s \s \u \e \d \space \n \e \w \space \d \r \a \f \t \space \g \u \i \d \a \n \c \e \  \t \h \a \t \space \d \o \e \s \space \n \o \t \space \r \e \c \o \m \m \e \n \d \space \l \e \n \a \l \i \d \o \m \i \d \e \space \( \R \e \v \l \i \m \i \d \) \space \f \o \r \space \t \r \e \a \t \i \n \g \space \p \a \t \i \e \n \t \s \space \w \i \t \h \  \m \y \e \l \o \d \y \s \p \l \a \s \t \i \c \space \s \y \n \d \r \o \m \e \. \space \  \F \o \r \space \m \o \r \e \space \d \e \t \a \i \l \s \, \space \g \o \space \t \o \  " ..."]]

[:content [\T \h \e \space \p \C \O \D \R \space \E \x \p \e \r \t \space \R \e \v \i \e \w \space \C \o \m \m \i \t \t \e \e \space \( \p \E \R \C \) \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \t \h \e \  \f \u \n \d \i \n \g \space \o \f \space \p \e \r \t \u \z \u \m \a \b \space \i \n \space \c \o \m \b \i \n \a \t \i \o \n \space \w \i \t \h \space \t \r \a \s \t \u \z \u \m \a \b \space \a \n \d \space \a \space \t \a \x \a \n \e \space \c \o \n \d \i \t \i \o \n \a \l \space \o \n " ..."]]

[:content [\E \v \e \r \o \l \i \m \u \s \space \( \A \f \i \n \i \t \o \r \) \space \i \s \space \n \o \t \space \r \e \c \o \m \m \e \n \d \e \d \space \a \s \space \a \n \space \N \H \S \- \f \u \n \d \e \d \space \t \r \e \a \t \m \e \n \t \space \f \o \r \space \a \space \t \y \p \e \space \o \f \space \a \d \v \a \n \c \e \d \space \b \r \e \a \s \t \space \c \a \n \c \e \r \space \b \e \c \a \u \s \e \space \i \t \space \i \s \space \n \o \t " ..."]]

[:content [\1 \3 \space \N \o \v \e \m \b \e \r \space \2 \0 \1 \3 \space \- \  \H \e \a \l \t \h \space \C \a \n \a \d \a \space \h \a \s \space \a \p \p \r \o \v \e \d \space \T \r \i \s \e \n \o \x \space \( \a \r \s \e \n \i \c \space \t \r \i \o \x \i \d \e \) \space \f \o \r \space \r \e \l \a \p \s \e \d \space \o \r \space \r \e \f \r \a \c \t \o \r \y \space \a \c \u \t \e \space \p \r \o \m \y \e \l \o \c \y \t \i \c \space \l \e \u \k \e \m \i \a \space \( \A \P \L \) \. \  \space \T \h \i \s \space \w \a \s " ..."]]

[:content [\5 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \  \T \h \e \space \p \C \O \D \R \space \E \x \p \e \r \t \space \R \e \v \i \e \w \space \C \o \m \m \i \t \t \e \e \space \( \p \E \R \C \) \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \t \h \e \space \f \u \n \d \i \n \g \space \o \f \space \b \r \e \n \t \u \x \i \m \a \b \space \v \e \d \o \t \i \n \space \( \A \d \c \e \t \r \i \s \) \space \f \o \r \space \u \s \e \space \a \s " ..."]]

[:content [\C \e \l \l \space \T \h \e \r \a \p \e \u \t \i \c \s \, \space \I \n \c \. \  \h \a \s \  \r \e \p \o \r \t \e \d \space \t \h \a \t \space \t \h \e \  \T \r \a \n \s \p \a \r \e \n \c \y \space \C \o \m \m \i \s \s \i \o \n \  \( \C \o \m \m \i \s \s \i \o \n \space \d \e \space \l \a \space \T \r \a \n \s \p \a \r \e \n \c \e \  \space \o \r \space \C \T \) \space \o \f \space \t \h \e \  \F \r \e \n \c \h \space \N \a \t \i \o \n \a \l \space \H \e \a \l \t \h \space \A \u \t \h \o \r \i \t \y \  \( \H \a \u \t \e \space \A \u \t \o \r \i \t \e \space \d \e \space \S \a \n \t \e \space \o \r " ..."]]

[:content [\T \h \e \space \p \C \O \D \R \space \E \x \p \e \r \t \space \R \e \v \i \e \w \space \C \o \m \m \i \t \t \e \e \space \( \p \E \R \C \) \space \h \a \s \space \r \e \c \o \m \m \e \n \d \e \d \space \t \h \e \  \f \u \n \d \i \n \g \space \o \f \space \M \e \k \i \n \i \s \t \space \( \t \r \a \m \e \t \i \n \i \b \) \  \i \n \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \B \R \A \F \space \V \6 \0 \0 \space \m \u \t \a \t \i \o \n \- \p \o \s \i \t \i \v \e \space \u \n \r \e \s \e \c \t \a \b \l \e \space \o \r \space \m \e \t \a \s \t \a \t \i \c " ..."]]